In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Two columns page ei  


Organised by the European Association for Cardiovascular Prevention and Rehabilitation, this educative and practical congress covers everything from Exercise Basic & Translational Research, to Epidemiology & Population Science and Sports Cardiology.

Spotlight of the Congress

Addressing inequalities in cardiovascular health' is the theme of EuroPRevent 2015 – the EACPR’s annual congress - Discover sessions dedicated to the theme.


These sessions are essential if we are to learn and be inspired by the success stories and challenges of our colleagues. You can also read reports and detailed analysis of the state of CVD prevention and rehabilitation in countries across Europe, published each month by the EACPR in its 'Prevention in your Country' initiative.



EuroPRevent 2015 has over 40 scientific sessions,  but be sure not to miss these highlights.

The infarction is on the other side of the street: geographical inequalities in cardiovascular disease

15 May 2015, 08:30, Room: Lisboa

A gradient across London...losing one year/life for every tube stop from Westminster to East London

Doctor Sandeep Gupta, London UK                   

  • Why is this a ‘not to be missed’ session?
    CHD death rates may be coming down in the UK and other Developed Countries, but stark inequalities remain, even within the same town or city!
  • What will delegates learn during your session?
    1. The current picture of CHD morbidity and mortality in UK, the gains, the achievements and aspects of the 'failings'.
    2. The diversity of a population and how culture and ethnicity may be co-factors or 'independent' CV risk factors.
    3. Behind the spectrum of differing CHD death rates, the role of the healthcare profession, the patient, the Policy makers and even Industry.
  • How will it impact patient care?
    We may be winning with reducing CHD death rates but more work and understanding is vital to address inequality in event rate and survival ... debate is needed



Is it really a lost generation? Lifestyle, sedentary behaviour and early preventive measures in childhood and adolescence

15 May 2015, 11:00, Room: Lisboa

Effect of a lifestyle intervention on adiposity and fitness in socially disadvantaged subgroups of preschoolers: a cluster-randomized trial (Ballabeina)

Associate Professor Pedro Marques-Vidal, Lausanne CH 

  • Why is this a ‘not to be missed’ session?
    Paediatric obesity is increasing in many countries and affects increasingly younger children
  • What will delegates learn during your session?
    School intervention need to be multifactorial and intensive to be effective.
    Implication of parents in child obesity prevention is paramount
  • How will it impact patient care?
    Management of paediatric obesity is a global issue that needs to involve children, parents, teachers, school directors, politicians and health professionals





Prevention works! An international perspective

15 May 2015, 11:00, Room: Porto

Prevention in Brazil

Professor Claudio Araujo, Rio De Janeiro, BR               

  • Why is this a ‘not to be missed’ session?
    Considering the large national and regional diversities and inequalities,  interesting, creative and quite unique successful approaches and/or strategies have been adopted for advancing non pharmacological prevention of cardiovascular diseases and will be presented at the session
  • What will delegates learn during your session?
    1. How to increase population awareness for the relevance of exercising regularly,  to follow good eating habits and to avoid or to quit smoking.
    2. How to more precisely develop strategies focusing on special population subgroups, e.g. children and adolescents.
    3. How to benefit from major international sport events and growing interest in specific mass events/competitions, e.g. marathons, to stimulate the adoption of a more regular and intense physical activity/exercise pattern for all population.
  • How will it impact patient care?
    A substantial fraction of deaths due to chronic diseases could be eliminated if a healthier lifestyle is more often adopted by all populations of the world. Precise and persistent action of health professionals are the key for the success of this strategy.


Prevention in India

Doctor Geevar Zachariah Arimpur, Thrissur, IN                

  • Why is this a ‘not to be missed’ session?
    Preventive cardiology from different regions of the world will be a stimulating experience.
  • What will delegates learn during your session?
    1. Will policy initiatives by the administration translate into visible improvements in risk factor burden?
    2. How to improve compliance of medications in secondary prevention?
    3. Role of community health workers in developing countries in reducing risk factor burden.
  • How will it impact patient care?
    Knowledge gained can be utilized in developing and implementing simple and practical strategies to prevent coronary heart disease and its risk factors


Prevention in Russia

Professor Nana-Goar Pogosova, Moscow RU                

  • Why is this a ‘not to be missed’ session?
    Cardiovascular diseases (CVD) account for 55.7% deaths in the Russian Federation (29.4% caused by coronary heart disease and 17.6% - by strokes) (2013). CVD are responsible for 3.9 times more deaths in Russia than cancers.
    Russia is a very big country with large mortality inequalities. One the lowest CVD mortality rate is found in Moscow - 362.0 per 100 000 population in 2013 (age-standardized to the European standard population).
    There is a 30% decline in CVD mortality in the Russian Federation since 2003.
    In 2013 the life expectancy in Russia reached 71 years, in Moscow- 76.4 years.What are the key components of success?


Prevention in Saudi Arabia

Doctor Najeeb Jaha, Dammam, SA                

  • Why is this a ‘not to be missed’ session?
    What lesson have we learned from PURE in the region, how should we move and act?
  • What will delegates learn during your session?
    1. No matter if you are good at acute management of CVD , it might be worthless if not integrated with excellent prevention.
    2. Cardiac rehabilitation program including prevention and should be delivered in different modalities that suite your population.
  • How will it impact patient care?
    Cardiac rehabilitation in a classic phase II structural program or communities based program (Euroaction) might be the best modalities to implement primary and secondary prevention.




Does individual risk prediction increase inequality? The issue of socioeconomic status as a risk predictor

15 May 2015, 14:00, Room: Lisboa

The contribution of educational class in improving accuracy of cardiovascular risk prediction across European regions

Professor Marco Ferrario, Varese, Italy                  

  • Why is this a ‘not to be missed’ session?
    The relatively poorer accuracy of the SCORE predictive equation assessed in UK men of the lower social classes, if true for all European people, may worsen social inequalities in CVD mortality.
  • What will delegates learn during your session?
    The addition of education to the SCORE risk in CVD prediction models improved discrimination and risk classification in European men and in Scandinavian women.
    The improvement was mostly driven by a correct re-classification of events in less educated men and by a re-classification of non-events among women.
  • How will it impact patient care?
    We recommend the inclusion of education in SCORE CVD risk equation in men, to improve social equity in primary prevention.


Modelling the impact of individual risk prediction strategies versus population level strategies on socioeconomic equality in CVD

Doctor Martin O’Flaherty, Liverpool, UK                    

  • Why is this a ‘not to be missed’ session?
    Prevention is key to reduce the unequal burden of Cardiovascular disease, but considerable debate still exists on how to do it: individuals, populations or both?
  • What will delegates learn during your session?
    1. How social class modify risk prediction in Europe
    2. Why ethnicity matters when tackling cardiovascular risk
    3. Should we focus CVD prevention on individuals or in populations?
  • How will it impact patient care?
    This session aims to update current thinking on how socioeconomics determinants of Health influence our decisions on how to prevent cardiovascular disease.





Today´s challenges for Africa's cardiology

16 May 2015, 08:30, Room: Lisboa

Focus on prevention or revascularization?

Doctor Ana Olga Mocumbi, Maputo, MZ                    

  • Why is this a ‘not to be missed’ session?
    Cardiovascular disease is one of the biggest challenges in preventive cardiology in Africa, where diseases related to usual risk factors are superimposed to a high burden of infectious and nutritional cardiovascular conditions.
  • What will delegates learn during your session?
    1. The unique epidemiological pattern of cardiovascular disease and the determinants of outcomes in Africa
    2. Recent advances in knowledge through innovative research driven by African scientists
    3. The “best buys” for preventive and interventional cardiology in Africa
  • How will it impact patient care?
    “In this era of easy migration of populations between different regions of the world the knowledge learnt in this session aims to improve care for patients of African descent and those with recent stays in this continent, by raising practitioner’s attention to specificities of tropical neglected cardiovascular diseases that are frequent in these populations.”


Cardiac Rehabilitation in socio-economic deprived individuals

Doctor Philip Ades, S. Burlington, US                   

  • Why is this a ‘not to be missed’ session?
    Low socio-economic status (SES) patients are high risk patient who are least likely to attend CR.
  • What will delegates learn during your session?
    1. Low SES patients are very high risk for recurrent CV events
    2. Low SES patients are least likely to attend cardiac rehabilitation (CR)
    3. Low SES patients generally make similar gains as other CR patients but may need a different approach
  • How will it impact patient care?
    This session will aid in identifying and recruiting low SES patients to CR and will discuss CR programming.